•
Feb 25, 2024

Lifecore Biomedical Q3 2024 Earnings Report

Total Revenue
$35.7M
Previous year: $27.6M
+29.4%
EPS
$0.4
Previous year: -$0.22
-281.8%
Adjusted EBITDA
$6.38M
Previous year: $1.45M
+339.5%
Gross Profit
$11.9M
Previous year: $5.98M
+99.0%
Cash and Equivalents
$3.07M
Previous year: $2.95M
+4.2%
Free Cash Flow
-$7.79M
Previous year: -$18.8M
-58.6%
Total Assets
$246M
Previous year: $237M
+4.1%

Lifecore Biomedical

Lifecore Biomedical

Lifecore Biomedical Revenue by Segment